Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edem

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. DPZ
4. ACN
5. IBM
6. META
7. PLTR
8. MSFT
9. MHTLY
10. NAVN

Go back to Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edem
Dominion Resources (NYSE: D) Delayed: 68.04 --0 (-0%)
Previous Close $68.04    52 Week High $78.97 
Open $68.04    52 Week Low $64.54 
Day High $68.04    P/E 56.70 
Day Low $68.04    EPS $1.20 
Volume 767       

(AMEX: IVBIY) Delayed: 39.25 --0 (-0%)
Previous Close $39.25    52 Week High $ 
Open $39.25    52 Week Low $ 
Day High $39.25    P/E N/A 
Day Low $39.25    EPS $ 
Volume 2       

Ryder System (NYSE: R) Delayed: 265.06 --0 (-0%)
Previous Close $265.06    52 Week High $80.15 
Open $265.06    52 Week Low $45.12 
Day High $265.06    P/E 57.25 
Day Low $265.06    EPS $4.63 
Volume 122